| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/19/2008 | US20080146570 Chemical Compounds |
| 06/19/2008 | US20080146567 5-HT5A receptor antagonists; depression, anxiety disorders, schizophrenia, panic disorders, agoraphobia, social phobia, obsessive compulsive disorders, post-traumatic stress disorders, pain, memory disorders, dementia, disorders of eating behaviors, sexual dysfunction, sleep disorders, drug withdrawal |
| 06/19/2008 | US20080146566 treatment of diseases mediated by cytokines; N-cyclopropyl-4-methyl-3-(1-oxoisoquinolin-2(1H)-yl)benzamide; rheumatoid arthritis, asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, multiple sclerosis, AIDS, septic shock, congestive heart failure, ischaemic heart disease, psoriasis |
| 06/19/2008 | US20080146564 the major cause of lower respiratory tract illness during infancy and childhood |
| 06/19/2008 | US20080146563 1,7-Naphthyridines as Pde4 Inhibitors |
| 06/19/2008 | US20080146562 Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 06/19/2008 | US20080146547 e.g. 4-Chloro-1-hydroxy-phthalazine-6-carboxylic acid [4-chloro-3'-(2-dimethylamino-ethoxy)-biphenyl-3-yl]-amide; multifunctioning protein kinase inhibitors; anticarcinogenic, antiinflammatory, antidiabetic agent, neurodegenerative diseases |
| 06/19/2008 | US20080146546 Bicyclic and Tricyclic Heteroaromatic Compounds |
| 06/19/2008 | US20080146536 2-Aminoimidazopyridines for treating neurodegenerative diseases |
| 06/19/2008 | US20080146533 Containing tertiary amine linked pyrrolidine, azetidine, morpholine or piperidine group; inhibiting GlyCer synthase, lowering glycosphingolipid levels; collagen vascular diseases, atherosclerosis, diabetic renal hypertrophy |
| 06/18/2008 | EP1932830A1 Sulfonamides and their use as a medicament |
| 06/18/2008 | EP1931622A1 Pesticide phenyloxy substituted phenylamidine derivatives |
| 06/18/2008 | EP1931347A2 Piperazine derivatives |
| 06/18/2008 | CN101203500A Substituted arylamine compounds and uses as 5-HT6 moderator thereof |
| 06/18/2008 | CN101200457A Dihydro pteridinone, method for making the same and uses as pharmaceutical preparation thereof |
| 06/17/2008 | US7388031 Reacting an epoxy compound with a aminocylcohexane-phenyl derivative; useful as anti-obesity, anti-diabetic, cicatrizing and tocolytic medicinal products |
| 06/17/2008 | CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 06/12/2008 | WO2008070831A2 Bisbenzamidines and bisbenzamidoximes for the treatment of human african trypanosomiasis |
| 06/12/2008 | WO2008070606A1 Hydrofluoroethξr compounds and processes for their preparation and use |
| 06/12/2008 | WO2007148208A3 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 06/12/2008 | WO2007127639A3 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
| 06/12/2008 | US20080139630 Tissue-selective androgen receptor modulators (SARMs); male hypogonadism, prostate cancer, benign prostate hyperplasia, sarcopenia, rheumatoid arthritis and osteoarthritis; N-((5-cyclopropyl-2-fluoropyridin-3-yl)methyl)-2-phenylbutanamide for example |
| 06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
| 06/12/2008 | US20080139564 Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| 06/12/2008 | US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/12/2008 | US20080139556 1-(3-Trifluoromethyl-benzenesulfonyl)-piperidine-2-carboxylic acid [(S)-1-(4-dimethylamino-phenylcarbamoyl)-2-(4-methoxy-phenyl)-ethyl]-amide;FK-binding protein/immunophilins modulator; neurodegenerative diseases; Parkinson's disease, multiple sclerosis, Alzheimer's disease, stroke, spinal cord injury |
| 06/12/2008 | US20080139539 6-{[(2-{4-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-1-piperazinyl}ethyl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 06/12/2008 | US20080139534 Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis |
| 06/11/2008 | EP1930308A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 06/11/2008 | EP1928818A1 Pesticide benzyloxy- and phenetyl-substituted phenyl-amidine derivatives |
| 06/11/2008 | EP1727809B1 Substituted morpholine and thiomorpholine derivatives |
| 06/11/2008 | EP1485348B1 Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/11/2008 | CN101198604A NPY antagonists, preparation and use |
| 06/11/2008 | CN101198601A Methods and intermediates for the preparation of optionally radio-labeled imatinib |
| 06/10/2008 | US7385063 Method for preparing imidazole derivatives |
| 06/10/2008 | US7385060 4-Methylpropiophenone is reacted with piperidine hydrochloride and 1,3-dioxolane in the presence of an acid serving as a catalyst, and the tolperisone obtained in the form of an acid addition salt is separated by filtering after the reaction mixture has cooled down; improved purity, simplification |
| 06/10/2008 | US7385054 For use as contrast media; x-ray diagnosis and magnetic resonance imaging |
| 06/10/2008 | US7384980 Derivatives of 3,3-diphenylpropylamines |
| 06/10/2008 | US7384960 Cannabinoid CB1 receptor antagonists; e.g. substituted 1,5-dihydroisothiochromeno[4,3-c]pyrazole-3-carboxamide compounds; schizophrenia, memory, appetite disorders |
| 06/10/2008 | US7384936 Carboxamidine derivatives and their use in the treatment of vascular diseases |
| 06/10/2008 | CA2393995C Novel benzene sulfonamide derivatives, their preparation and pharmaceutical compositions containing them |
| 06/10/2008 | CA2327743C Organic articles |
| 06/10/2008 | CA2129046C Opioid diarylmethylpiperazines and piperidines |
| 06/05/2008 | US20080132678 Such as N-(4-morpholine)carbonyl-(O-benzyl)-L-tyrosine-L-leucine boronic acid for reducing rate of degradation of proteins; proteasome inhibitors |
| 06/05/2008 | US20080132578 venlafaxine metabolites used for treating and preventing psychological disorders, Parkinson's disease, epilepsy, obesity, incontinence or Alzheimer's disease; side effect reduction |
| 06/05/2008 | US20080132518 novel polymorphic forms of aripiprazole in the treatment of schizophrenia; properties suitable for pharmaceutical processing on a commercial scale |
| 06/05/2008 | US20080132514 bi-functional organic molecules which combine serotonin transporter reuptake inhibition with serotonin (5-HT, such as 5-HT2A) receptor antagonism in one molecular entity |
| 06/05/2008 | US20080132507 Hydrazide Derivatives |
| 06/05/2008 | US20080132497 Novel Heterocycles |
| 06/04/2008 | EP1927594A1 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 06/04/2008 | EP1927587A2 Conjugated dienamides, methods of production thereof, compositions containing same and uses thereof |
| 06/04/2008 | EP1926706A2 Pesticide bi-phenyl-amidine derivatives |
| 06/04/2008 | EP1343775B1 Piperazine derivatives |
| 06/04/2008 | CN101193852A Analogs of 4-hydroxyisoleucine and uses thereof |
| 06/04/2008 | CN100391951C Synthesis method of butadiene morpholine |
| 06/04/2008 | CN100391941C Amidemercaptan and thioderivative thereof |
| 06/03/2008 | US7381840 2-Hydroxy-1,2,3,4-tetrahydronaphthalenes substituted in the 8-position with a biphenylcarbonylamino-, biphenylcarbonylaminoalkyl-, biphenylaminocarbonylamino-, or biphenylaminocarbonylaminoalkyl- group; vanilloid receptor antagonists |
| 06/03/2008 | US7381827 Processes and intermediates |
| 06/03/2008 | US7381821 Reacting 4-(alpha-(p-chlorophenyl)benzyl)-1-leaving group-alkylpiperazine with protected 1-hydroxy-1-(4-(p-hydroxyphenyl)-3-butynyl)urea to form 1-(4-(p-(4-(alpha-(p-chlorophenyl)benzyl)-1-piperazin-1-ylalkyl)phenyl)-3-butynyl)-1-hydroxyurea; preparation of intermediates |
| 06/03/2008 | US7381813 A modified estrogen receptor alpha ligand binding domain containing an amino acid modification in region 1, at region 2, or atleast one amino acid modifiation in both of regions, and these domain interacts with a nonendogenous ligand |
| 06/03/2008 | US7381749 Sulfonamides as inhibitors of histone deacetylase for the treatment of disease |
| 06/03/2008 | US7381728 growth hormone secretagogue receptors agonists; N-[3-(cis-3,5-Dimethyl-1-piperazinyl)-4-(methyloxy)phenyl]-5-(2-pyridinyl)-2-thiophenesulfonamide; synthesis through the coupling of the piperazine derivatives with sulfonylhalides or pentafluorophenyloxy protected derivatives, or through interconversion |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2334579C Secondary aspartic acid amide esters |
| 05/29/2008 | WO2008064039A2 Prostaglandin prodrugs as ocular hypotensive agents |
| 05/29/2008 | WO2008064036A1 Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| 05/29/2008 | WO2008061954A1 Novel co-initiators |
| 05/29/2008 | US20080125429 1-{[5-[4-(Methylsulfonyl)phenoxy]-2-(2-pyridinyl)-1H-benzimidazol-6-yl]methyl}-5-thioxo-2-pyrrolidinone;glucokinase activator; antidiabetic agents; obesity; prevention of retinopathy, nephropathy, neurosis, ischemic cardiopathy, arteriosclerosis; antiischemic agents; cardiotonic agents |
| 05/29/2008 | US20080125424 Derivatives of urea and related diamines, methods for their manufacture, and uses therefor |
| 05/29/2008 | US20080125417 4-Tert-Butyl-N-(2-methyl-3-{2-[4-(morpholine-4-carbonyl)-phenylamino]-pyrimidin-4-yl}-phenyl)-benzamide;enzyme inhibitors of Burton's tyrosine kinase (Btk); autoimmune diseases; antiinflammatory/-arthritic agents; X-linked agammaglobulinaemia; antiallergens; osteoporosis; determining the presence Btk |
| 05/29/2008 | US20080125412 Containing a diazacycloalkane ring, especially a 1,4-diazepane ring, e.g., N-p-((4-(alpha-phenylmethoxycarbonylmethyl)-1,4-diazepan-1-yl)phenyl)-o-biphenylcarboxamide, for the treatment of hyperlipidemia, obesity and type II diabetes. |
| 05/29/2008 | US20080124384 Heteroaryl Substituted Piperazinyl-Pyridine Analogues |
| 05/29/2008 | US20080124285 Merocyanine Derivatives for Cosmetic Use |
| 05/29/2008 | CA2689293A1 Prostaglandin prodrugs |
| 05/28/2008 | EP1925609A1 Novel-co-initiators |
| 05/28/2008 | EP1924554A1 Sulphonamide derivatives |
| 05/28/2008 | EP1673078B1 Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease |
| 05/28/2008 | CN100390156C Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 05/28/2008 | CN100390135C Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 05/28/2008 | CN100390131C Unsaturated 1-amino-alkylcyclohexane NMDA, 5HT3 and neuronal nicotinic receptor antagonists |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378448 Diphenylether amide derivatives as opioid receptor antagonists |
| 05/27/2008 | US7378447 Muscarinic agonists |
| 05/27/2008 | US7378436 Substituted N-[pyrrolidin-3-yl] benzamides or naphthamides; serotonin and noradrenaline receptor antagonists; urinary incontinence; arylation of the amino pyrrolidine with a carboxylic acid or acyl halide and then deprotecting |
| 05/27/2008 | US7378420 4-[(2,4-dichloro-phenyl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide; conjugated to polyethylene glycol; analgesic, antidiabetic and anticarcinogenic agent, antidepressant, anxiolytic agent |
| 05/27/2008 | US7378412 Pharmaceutical compounds |
| 05/27/2008 | US7378409 Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity |
| 05/27/2008 | CA2351232C Bifunctional photoinitiators suitable for photopolymerization and photopolymerizable systems containing the same |
| 05/22/2008 | WO2008061108A2 Phthalazine derivatives |
| 05/22/2008 | WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
| 05/22/2008 | US20080119649 Halocombstatins and methods of synthesis thereof |
| 05/22/2008 | US20080119486 Benzoyl-piperazine derivatives |
| 05/21/2008 | EP1812395B1 Method for the preparation of aripiprazole, and corresponding intermediates and their preparation |
| 05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
| 05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/20/2008 | US7375229 Dihydro-dibenzo[B,E]oxepine based selective estrogen receptor modulators, compositions and methods |
| 05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
| 05/20/2008 | US7375125 Dietetics, cognition activators, cardiovascular disorders, analgesics, immunomoderators |